[Low molecular weight heparin in pregnancy. Report of three cases with pure mitral stenosis].

F Ayala, H Murillo, L Lepe, S Solorio, A Almazán, R Enciso, R Madrid, L Antonio, O Martínez, A García Manzano
{"title":"[Low molecular weight heparin in pregnancy. Report of three cases with pure mitral stenosis].","authors":"F Ayala,&nbsp;H Murillo,&nbsp;L Lepe,&nbsp;S Solorio,&nbsp;A Almazán,&nbsp;R Enciso,&nbsp;R Madrid,&nbsp;L Antonio,&nbsp;O Martínez,&nbsp;A García Manzano","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Three pregnant women with 5 +/- 1.7 weeks of pregnancy and mitral stenosis are described. Their valve area were < 1.0 cm2. They received medical treatment with little improvement and were included in our valvotomy percutaneous mitral (VPM) program with Inoue technique before their 30th week of pregnancy. Before they were treated with low molecular weight heparin (LMWH), Enoxiparin) as prophylaxis of intracavitary thrombus formation transthoracic and transesophageal echocardiogram demonstrated the absence of thrombus. We used 40 mgs. subcutaneous injection once a day during 16 weeks. Repeated transthoracic and transesophageal echocardiogram during VPM showed no evidence of intracavitary thrombus. Complete blood count and coagulation parameters remained within normal limits. The three cases delivered a healthy products. In conclusion, although this series is small, we show that the LMWH can be used in the first trimester of pregnancy as prophylactic treatment instead of oral anticoagulant treatment.</p>","PeriodicalId":75556,"journal":{"name":"Archivos del Instituto de Cardiologia de Mexico","volume":"69 4","pages":"344-9"},"PeriodicalIF":0.0000,"publicationDate":"1999-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archivos del Instituto de Cardiologia de Mexico","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Three pregnant women with 5 +/- 1.7 weeks of pregnancy and mitral stenosis are described. Their valve area were < 1.0 cm2. They received medical treatment with little improvement and were included in our valvotomy percutaneous mitral (VPM) program with Inoue technique before their 30th week of pregnancy. Before they were treated with low molecular weight heparin (LMWH), Enoxiparin) as prophylaxis of intracavitary thrombus formation transthoracic and transesophageal echocardiogram demonstrated the absence of thrombus. We used 40 mgs. subcutaneous injection once a day during 16 weeks. Repeated transthoracic and transesophageal echocardiogram during VPM showed no evidence of intracavitary thrombus. Complete blood count and coagulation parameters remained within normal limits. The three cases delivered a healthy products. In conclusion, although this series is small, we show that the LMWH can be used in the first trimester of pregnancy as prophylactic treatment instead of oral anticoagulant treatment.

低分子量肝素在妊娠中的应用。单纯二尖瓣狭窄3例报告。
本文描述了3例妊娠5±1.7周伴有二尖瓣狭窄的孕妇。瓣膜面积均< 1.0 cm2。她们接受了药物治疗,但几乎没有改善,并在怀孕30周之前使用Inoue技术进行了经皮二尖瓣切开术(VPM)计划。在给予低分子肝素(LMWH)、依诺皮素(enoxparin)预防腔内血栓形成之前,经胸和经食管超声心动图显示没有血栓形成。我们用的是40毫克。每天皮下注射一次,持续16周。VPM期间多次经胸、经食管超声心动图未见腔内血栓。全血细胞计数和凝血指标均在正常范围内。这三个案例提供了健康的产品。总之,尽管这一系列研究较少,但我们表明低分子肝素可以在妊娠前三个月作为预防性治疗而不是口服抗凝治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信